Airborne 1 O 2 Delivery via a Superhydrophobic Dressing as a Pathway to Next‐Generation Wound Therapies, an In Vivo Murine Burn Model Study
Open Access
- 27 March 2026
- journal article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (21) , e71083
Abstract
Antimicrobial photodynamic therapy (aPDT) has been investigated as a promising therapy for treating wound infections. However, its clinical application is limited by tissue hypoxia, poor photosensitizer (PS) penetration, and off‐target toxicity. In this work, we use a light‐activated, contactless aPDT system that delivers airborne singlet oxygen ( 1 O 2 ) via a compliant, transparent superhydrophobic (SH) bandage. The verteporfin‐coated SH membrane generates 1 O 2 while minimizing direct contact between PS and wound tissue. In a murine third‐degree burn model infected with methicillin‐resistant Staphylococcus aureus (MRSA) or Pseudomonas aeruginosa , a single SH‐aPDT treatment significantly reduces bacterial burden and accelerates wound closure. It enhances collagen deposition, stimulates angiogenesis, increases α‐SMA + myofibroblast activity, and decreases COX‐2 expression, indicating attenuated inflammatory signaling. Administration of two treatments 24 h apart further augments bacterial clearance and improves healing outcomes. SH‐aPDT also promotes a pro‐regenerative immune response, as evidenced by increased M2 macrophages. These findings demonstrate that airborne 1 O 2 delivery through SH bandages is a promising approach for the management of infected, hypoxic, or antibiotic‐resistant wounds, with great potential for clinical translation in wound care.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R41AI183969)
- Air Force Office of Scientific Research (FA9550‐20‐1‐0063)
- Air Force Office of Scientific Research (FA9550‐23‐1‐0656)
This publication has 48 references indexed in Scilit:
- Ru(II)‐Based Photo‐Antibiotics: Light‐Driven Eradication of Bacterial Biofilm and Rapid Healing of Infective Wounds in Wistar RatChemistry – A European Journal, 2025
- Injectable ROS/pH‐Responsive Hydrogel for Synergistic Chemo‐Photodynamic Tumor Therapy and Enhanced Wound HealingAdvanced Healthcare Materials, 2025
- Photosensitizer associated with efflux pump inhibitors as a strategy for photodynamic therapy against bacterial resistanceEuropean Journal of Medicinal Chemistry, 2024
- Self‐Assembled Verteporfin Nanoparticles for Photodynamic and Light‐Independent Therapy in GlioblastomaAdvanced NanoBiomed Research, 2024
- Photodynamic therapy offers a novel approach to managing miltefosine-resistant cutaneous leishmaniasisBiomedicine & Pharmacotherapy, 2024
- Dramatic destruction of methicillin-resistant Staphylococcus aureus infections with a simple combination of amoxicillin and light-activated methylene blueJournal of Photochemistry and Photobiology B: Biology, 2022
- Evaluation of photosensitizer-containing superhydrophobic surfaces for the antibacterial treatment of periodontal biofilmsJournal of Photochemistry and Photobiology B: Biology, 2022
- Towards effective cutaneous leishmaniasis treatment with light-based technologies. A systematic review and meta-analysis of preclinical studiesJournal of Photochemistry and Photobiology B: Biology, 2021
- Attaching NorA efflux pump inhibitors to methylene blue enhances antimicrobial photodynamic inactivation of Escherichia coli and Acinetobacter baumannii in vitro and in vivoBioorganic & Medicinal Chemistry Letters, 2018
- The Role of Vascular Endothelial Growth Factor in Wound HealingJournal of Surgical Research, 2009